| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8524976 | Biomedicine & Pharmacotherapy | 2018 | 8 Pages |
Abstract
Our data indicated that the high level of HDAC6 inhibited miR-148b via maintaining the low acetylation of histones H3 and H4 in the miR-148b promoter, thus rescuing Ezrin expression and promoting CHOP resistance in DLBCL.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Ni Sun, Chen-Yi Wang, Yi-Qun Sun, Ye-Jiao Ruan, Yue-Yue Huang, Tong Su, Xiao-Hai Zhou, He Huang, Wen-Jian Guo, Mu-Qing He, Rong-Xin Yao, Xiao-Ji Lin,